Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1
- 1 November 2007
- journal article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 84 (3-4) , 116-127
- https://doi.org/10.1016/j.prostaglandins.2007.05.001
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Heme Oxygenase-2 Is a Critical Determinant for Execution of an Acute Inflammatory and Reparative ResponseThe American Journal of Pathology, 2006
- Inhibition of Ocular Angiogenesis by Diced Small Interfering RNAs (siRNAs) Specific to Vascular Endothelial Growth Factor (VEGF)Current Eye Research, 2006
- A Biosynthetic Pathway Generating 12-Hydroxy-5,8,14-eicosatrienoic Acid from Arachidonic Acid Is Active in Mouse Skin MicrosomesThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Transfection of Cytochrome P4504B1 into the Cornea Increases Angiogenic Activity of the Limbal VesselsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Inhibitors of Cytochrome P450 4A Suppress Angiogenic ResponsesThe American Journal of Pathology, 2005
- Promoter activity and regulation of the corneal CYP4B1 gene by hypoxiaJournal of Cellular Biochemistry, 2004
- Inhibition of Angiogenesis by Adenovirus-Mediated sFlt-1 Expression in a Rat Model of Corneal NeovascularizationHuman Gene Therapy, 2001
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Oxidation and keto reduction of 12-hydroxy-5,8,10,14-eicosatetraenoic acids in bovine corneal epithelial microsomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytesBiochemistry, 1990